Expression and clinical significance of Wee1 in colorectal cancer (Q38737092)

6 September 2017

title

Expression and clinical significance of Wee1 in colorectal cancer (English)

1 reference

6 September 2017

1 reference

Kjersti Flatmark

1 reference

6 September 2017

Jahn M Nesland

1 reference

6 September 2017

Gunhild M Mælandsmo

1 reference

6 September 2017

Kjetil Boye

1 reference

6 September 2017

Eivind Valen Egeland

1 reference

6 September 2017

Vivi Ann Flørenes

1 reference

6 September 2017

language of work or name

1 reference

24 May 2016

1 reference

6 September 2017

1 reference

6 September 2017

1 reference

6 September 2017

1 reference

6 September 2017

page(s)

12133-12140

1 reference

p107wee1 is a dual-specificity kinase that phosphorylates p34cdc2 on tyrosine 15

6 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Forced mitotic entry of S-phase cells as a therapeutic strategy induced by inhibition of WEE1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Wee1 controls genomic stability during replication by regulating the Mus81-Eme1 endonuclease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Differential gene expression in colon carcinoma cells and tissues detected with a cDNA array

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

In silico analysis of kinase expression identifies WEE1 as a gatekeeper against mitotic catastrophe in glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

High expression of Wee1 is associated with poor disease-free survival in malignant melanoma: potential for targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

WEE1 kinase targeting combined with DNA-damaging cancer therapy catalyzes mitotic catastrophe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

WEE1 Kinase As a Target for Cancer Therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Combined inhibition of Chk1 and Wee1: in vitro synergistic effect translates to tumor growth inhibition in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Chk1 inhibition and Wee1 inhibition combine synergistically to impede cellular proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Combined inhibition of the cell cycle related proteins Wee1 and Chk1/2 induces synergistic anti-cancer effect in melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

S100A4 and metastasis: a small actor playing many roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Enrichment of nuclear S100A4 during G2/M in colorectal cancer cells: possible association with cyclin B1 and centrosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Asymmetric localization of the CDC25B phosphatase to the mother centrosome during interphase.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Active cyclin B1-Cdk1 first appears on centrosomes in prophase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

A genetic model for colorectal tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Prognostic value of thymidylate synthase, Ki-67, and p53 in patients with Dukes' B and C colon cancer: a National Cancer Institute-National Surgical Adjuvant Breast and Bowel Project collaborative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Investigation of the prognostic and predictive value of thymidylate synthase, p53, and Ki-67 in patients with locally advanced colon cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Cell cycle proteins predict recurrence in stage II and III colon cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

EMMPRIN is associated with S100A4 and predicts patient outcome in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Immunofluorometric assay for the metastasis-related protein S100A4: release of S100A4 from normal blood cells prohibits the use of S100A4 as a tumor marker in plasma and serum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Phase I Study of Single-Agent AZD1775 (MK-1775), a Wee1 Kinase Inhibitor, in Patients With Refractory Solid Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Preclinical evaluation of the WEE1 inhibitor MK-1775 as single-agent anticancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Cdc25 and Wee1: analogous opposites?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Control mechanism of the circadian clock for timing of cell division in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Colorectal liver metastases with a disrupted circadian rhythm phase shift the peripheral clock in liver and kidney.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-016-5081-3

Nuclear S100A4 is a novel prognostic marker in colorectal cancer

21 January 2018

1 reference

12 December 2020

The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer

1 reference

12 December 2020

Immunomagnetic detection of micrometastatic cells in bone marrow of colorectal cancer patients

1 reference

12 December 2020

The impact of cell proliferation markers and p53 mutation status on prognosis of non-metastatic colon cancer

1 reference

12 December 2020

WEE1 inhibition and genomic instability in cancer

1 reference

12 December 2020

Wee1 kinase as a target for cancer therapy

1 reference

12 December 2020

Nuclear localization of the metastasis-related protein S100A4 correlates with tumour stage in colorectal cancer

1 reference

12 December 2020

10.1007/S13277-016-5081-3

Identifiers

DOI

1 reference

Dimensions Publication ID

6 September 2017

1019589024

0 references

1 reference